Skip to main content

Table 1 Baseline demographics for non-infectious uveitis patients by treatment groups

From: Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA

 

CTS patients a

(N = 4,568)

IMS patients b

(N = 5,466)

BIO patients

(N = 1,694)

Gender, N (%)

  Male

1,839 (40.3%)

1,526 (27.9%)a

654 (38.6%)b

  Female

2,729 (59.7%)

3,940 (72.1%)a

1,040 (61.4%)b

Age, N (%)

   

  0–17,%

162 (3.5%)

350 (6.4%)a

153 (9.0%)a,b

  18-24

142 (3.1%)

170 (3.1%)a

77 (4.5%)a,b

  25-34

305 (6.7%)

388 (7.1%)a

173 (10.2%)a,b

  35-44

704 (15.4%)

868 (15.9%)a

390 (23.0%)a,b

  45-54

1,360 (29.8%)

1,683 (30.8%)a

472 (27.9%)a,b

  55-64

1,895 (41.5%)

2,007 (36.7%)a

429 (25.3%)a,b

Index year, N (%)

  2003

175 (3.8%)

219 (4.0%)

72 (4.3%)

  2004

401 (8.8%)

507 (9.3%)

151 (8.9%)

  2005

641 (14.0%)

723 (13.2%)

208 (12.3%)

  2006

730 (16.0%)

803 (14.7%)

250 (14.8%)

  2007

862 (18.9%)

1,088 (19.9%)

346 (20.4%)

  2008

1,063 (23.3%)

1,280 (23.4%)

420 (24.8%)

  2009

696 (15.2%)

846 (15.5%)

247 (14.6%)

Health insurance type, N (%)

  HMO

924 (20.2%)

924 (16.9%)a

282 (16.6%)a

  PPO

2,456 (53.8%)

3,216 (58.8%)a

1,014 (59.9%)a

  EPO

18 (0.4%)

34 (0.6%)a

7 (0.4%)a

  Indemnity

72 (1.6%)

94 (1.7%)a

29 (1.7%)a

  Other

1,098 (24.0%)

1,198 (21.9%)a

362 (21.4%)a

  1. HMO, health maintenance organization; PPO, preferred provider organization; EPO, extended provider organization. Chi-square tests were used to test differences in categorical variables. a,bData with superscripted letter(s) indicate a significant difference (P < 0.05) from the uveitis subtype represented by that letter.